First Wave Technologies Named as Top MedTech Startup 2022 by MedTech Outlook Magazine – Key Aspects of Clarity-IA Explained by CEO – Yahoo Finance
BATAVIA, NY / ACCESSWIRE / November 22, 2022 / First Wave Technologies, Inc. ("First Wave" "FWT" and "Company"), a medical device company developing products for the acute care and long-term care markets, announces it has been recognized by MedTech Outlook as the Company of the Year-Top MedTech Startup. The award highlights First Wave's Clarity-IA® advanced inhalational medical gas delivery system.
MedTech Outlook, a leading industry publication, works to monitor and inform the healthcare industry about innovative MedTech trends and solutions that can have meaningful impact on healthcare providers and patients. As such, MedTech Outlook aims to bridge the information gap between MedTech technology, providers, healthcare facilities, and medical institutions.
Regarding this acknowledgement, Brian Bell, CEO of First Wave stated, "We are very pleased to see that MedTech Outlook selected First Wave as a recipient of this award. It is an honor to be recognized amongst today's landscape of emerging and innovative healthcare products. With Clarity-IA having a strong IP foundation (58 patents/applications) and a 510(k) in progress, the timing of the award is appropriate. First Wave also acknowledges the contributions of the Company's Board of Directors and team members along with the expert physicians and other medical professionals who will be overseeing Clarity-IA's planned clinical trials. First Wave's ultimate goal is to offer cost savings to the overall healthcare system and offer the highest level of care to patients needing inhaled anesthesia.
Further information about First Wave, as shared by Mr. Bell in this feature article, can be found on the MedTech Outlook website as well as on the Company's corporate website.
About First Wave Technologies, Inc.
First Wave Technologies, Inc. is a medical device company developing products for the acute care and long-term care markets. The focus is to disrupt areas of healthcare with innovative products which have not seen meaningful change historically for the improvement of patient care. Current products are centered around improving the ease and accuracy of pharmaceutical delivery. For more information, please visit http://firstwavetechnologies.com.
Corporate Contact:
Brian Bell
Chief Executive Officer and Director
First Wave Technologies, Inc.
99 MedTech Dr.
Batavia, New York 14020
Phone: +1 877.784.0269
E-mail: info@firstwavetechnologies.com
Investor Contact:
Jennifer K. Zimmons, Ph.D., MBA
Investor Relations
Zimmons International Communications, Inc.
Phone: +1 917.214.3514
E-mail: jzimmons@zimmonsic.com
This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to our IsoVENT and our partnership with Canon. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with the development and commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the IsoVENT device, (5) the risk that the Company does not execute its business plan or that the companies engaged to develop and obtain regulatory approval for the IsoVENT device do not execute their plans, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.
SOURCE: First Wave Technologies, Inc.
View source version on accesswire.com:
https://www.accesswire.com/727595/First-Wave-Technologies-Named-as-Top-MedTech-Startup-2022-by-MedTech-Outlook-Magazine–Key-Aspects-of-Clarity-IA-Explained-by-CEO
With Thanksgiving just around the corner, one of the things many investors are giving thanks for is a handful of outperforming stocks. With the S&P 500 index still down about 17% YTD as of Nov….
Tough times are coming. But you can still make money.
Novavax (NASDAQ: NVAX) shares were down more than 16% in late-afternoon trading. On Tuesday, a dispute between the biotech maker of vaccines to treat infectious diseases and global nonprofit Gavi sent Novavax's shares dropping. On Monday, Novavax canceled its contract with Gavi, saying the nonprofit had breached an agreement to purchase, in advance, 350 million doses of Nuvaxovid, Novavax's COVID-19 vaccine.
It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as reflected in the main indexes’ performances. All are down by at least double-digits; the tech-heavy NASDAQ’s 30% drop has been the most acute, while the S&P 500 now sits 17% lower year-to-date. That said, while it’s hard to watch any owned stock sink to the bottom, the upside to the downside is that investors
FTX collapsed. These players held the keys.
Wall Street believes mean reversion and geopolitical tensions could play a key role
Coinbase CEO Brian Armstrong is reassuring users about the financial health of the Nasdaq-listed crypto exchange, following a tweet — since deleted — from CZ of Binance.
In this article, we talk about 10 stocks that billionaire Ray Dalio dumped from his portfolio. If you want to see more stocks in this selection, check out Billionaire Ray Dalio is Dumping These 5 Stocks. Ray Dalio is an American billionaire hedge fund manager, philanthropist, and the founder of Bridgewater Associates, one of the […]
Market conditions these days are best described as ‘unsettled.’ Inflation was lower in the October print, but remains stubbornly high, while the Fed’s reactive interest rate policy is pushing up the price of capital, but has not yet constricted retail or other purchasing activity – or inflation. Other headwinds include continued bottlenecks in global supply chains, made worse by recurring COVID lockdown policies in China, and the ongoing Russian war in Ukraine. So, should investors stick to a de
Tsakos (TNP) delivered earnings and revenue surprises of -31.48% and 8.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
In minds and numbers, Tesla remains the star of the automotive industry. The market capitalization of Elon Musk's group is above $532 billion at last check. Toyota , General Motors , Ford and Volkswagen are far behind with market values $199 billion, $57 billion, $56.5 billion and nearly $100 billion, respectively.
Some Twitter employees who chose to stay at the company as it transformed to "Twitter 2.0" are being shown the door.
Wharton Professor Jeremy Siegel says 90% of U.S. inflation is already gone, but Bill Ackman is warning investors not to forget about deglobalization.
The S&P 500 moved back above the key 4,000 level in a strong day for the market rally. Riots hit Apple's main China iPhone factory. Enphase Energy leads 5 stocks in buy areas.
Reuters China To Reportedly Impose Over $1B Fine On Jack Ma's Ant Group Ending 2-Year Long Regulatory Overhaul Ending Jack Ma's Ant Group's two-year-long regulatory feud, Chinese authorities will reportedly impose a fine of more than $1 billion on the billionaire's fintech company. China's central bank – which has been driving the revamp at Ant after the Xi Jinping-led administration scuttled the company's $37 billion IPO at the last minute in 2020 – is the regulator readying the fine. Warren Bu
Oil stocks are on the rise as Saudi Arabia's energy minister dispelled rumors that the country may increase output.
These supercharged income stocks, with yields ranging from 8.5% to 17.7%, were on billionaire money manager's buy lists during the third quarter.
There are mounting signals that the stock market has already marked its low point. That doesn't mean upside from here will be easy, however.
For anyone looking to get ahead in the investing game, following in the footsteps of stock picking legends is an obvious path to follow. Hardly any are more legendary than George Soros, forever known as the ‘man who broke the Bank of England,’ after pocketing a cool billion dollars in one day when betting against the Pound back in 1992. That single act, however, does not define Soros, who has made sound investment decisions throughout his career which bought decades-long returns of 30% to his Qu
PagSeguro Digital Ltd. (PAGS) delivered earnings and revenue surprises of 9.09% and 1.45%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?